ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances

Blood

Volumn 99, Issue 1, 2002, Pages 238-244

  Camacho, Emma ^b   Hernández, Luis ^b   Hernández, Silvia ^b   Tort, Frederic ^b   Bellosillo, Beatriz ^b   Beà, Silvia ^b   Bosch, Francesc ^b   Montserrat, Emili ^b   Cardesa, Antonio ^b   Fernández, Pedro L ^b   Campo, Elias ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE INACTIVATION; GENE LOSS; GENE MUTATION; GENETIC POLYMORPHISM; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION;

EID: 0036090306     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.238     Document Type: Article

References (44)

1. Mantle-cell lymphoma
2. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma
3. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
4. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis
5. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma
6. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas
7. Deletions and loss of expression of p161NK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas
8. Gain of 3q and deletion of 11 q22 are frequent aberrations in mantle cell lymphoma
9. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
10. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
11. The ATM gene in the pathogenesis of mantle-cell lymphoma
12. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma
13. ATM: From gene to function
14. The genetic defect in ataxia-telangiectasia
15. Inactivation of the ATM gene in T-cell prolymphocytic leukemias
16. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia
17. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia
18. ATM mutations in B cell chronic lymphocytic leukemia
19. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
20. Mantle cell lymphoma is characterized by inactivation of the ATM gene
21. ATM and ATR: Networking cellular responses to DNA damage
22. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
23. Sensing and responding to DNA damage
24. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks
25. Role for ATM in DNA damage-induced phosphorylation of BRCA1
26. Enhanced phosphorylation of p53 by ATM in response to DNA damage
27. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
28. ATM associates with and phosphorylates p53: Mapping the region of interaction
29. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene
30. Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in Israel
31. Restriction endonuclease fingerprinting (REF): A sensitive method for screening mutations in long, contiguous segments of DNA
32. Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice
33. Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction
34. Non-parametric stimulation from incomplete observations
35. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data
36. Ataxia-telangiectasia locus: Sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene
37. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
38. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage dis-equilibrium
39. The ATM gene and susceptibility to breast cancer: Analysis of 38 breast tumors reveals no evidence for mutation
40. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
41. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
42. Cancer risks in A-T heterozygotes
43. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations
44. The role of ATM in DNA damage responses and cancer